Alamar Biosciences, Inc. Common Stock (ALMR)

LABORATORY ANALYTICAL INSTRUMENTS

Headquarters: United States
Market Cap: $1.9B

About Alamar Biosciences, Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

SentiSense also tracks daily options readings for Alamar Biosciences, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.

Alamar Biosciences, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.